Fundraising Fox

4see Ventures

Venture capital

Chêne-Bougeries · Pre-Seed–Series B · 2 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

4see ventures invests in emerging leaders across climatech, sustainability, and healthcare, aiming to help build game-changing companies globally. Its current investment focus is on Swiss early-stage startups in climatech and sustainability. The firm backs founders defined by a strong passion for their mission and a dedication to hard work, seeking entrepreneurs with the ambition to change the world, a clear vision to disrupt markets, and executable plans to bring that vision to life. The name reflects a philosophy of foresight — anticipating market developments, patterns, and trends before they fully unfold.

Source: firm website, verified Aug 7, 2026.

Stage
Pre-Seed–Series B
Check
$432K – $1.1M
HQ
Chêne-Bougeries, CH
Instruments
Equity
Founded
2019
Tracked investments
9

Team · 2 people

from the firm's website & public directories

What they invest in

from 6 of 9 portfolio companies

Healthtech ×3Biotech ×2Deep Tech ×2Medical Devices ×2AI & Machine Learning ×1Circular Economy ×1Construction Tech ×1EdTech ×1

HQs:Switzerland×3

Investments · 9 tracked

founders shown can be your intro path
Distalmotiondistalmotion.comin𝕏

Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.

HealthtechMedical DevicesRoboticsLausanne, CH

PartnerDaniel Bertholet· solo GP

Co-investors415 CapitalPrivilège VenturesZühlke Ventures

FenXfenx.chin

FenX develops proprietary materials technology for sustainable, circular construction, aiming to produce affordable living spaces that reduce waste and improve energy efficiency.

Circular EconomyConstruction TechNew MaterialsZurich, CH

Dr. Alessandro Dutto(Co-founder, Formulation)Enrico Scoccimarro(CSO & Co-founder)Dr. Etienne Jeoffroy(CEO & Co-founder)Jens Diebold(COO)

PartnerDaniel Bertholet· solo GP

Co-investorsSupernova Invest

Goodwallgoodwall.ioin

Goodwall is a free social education app and B Corp that uses behavioral psychology and gamified design to teach young people future-ready skills.

EdTechFuture of WorkImpact & Social GoodSocialGeneva, CH

Taha BawaOmar Bawa

PartnerDaniel Bertholet· solo GP

Haya Therapeuticshayatx.comin𝕏

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)Daniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in

PartnerDaniel Bertholet· solo GP

Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures+ND Capital

NetGuardians

PartnerDaniel Bertholet· solo GP

Priothera Ltd.priothera.com

Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation.

BiotechHealthtech

Florent Gros(Founder & CEO)

PartnerDaniel Bertholet· solo GP

Co-investorsFountain Healthcare PartnersHealthCap

Staliclastalicla.com

PartnerDaniel Bertholet· solo GP

Co-investorsBeresford VenturesLIFTT

Transmutextransmutex.comin

Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes.

Deep TechEnergyMedical Devices

Franklin Servan-Schreiber(Founder & CEO)

PartnerDaniel Bertholet· solo GP

Co-investorsAlleyCorpAt One VenturesHCVCSteel AtlasUnion Square Ventures (USV)Verve Ventures+4 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has 4see Ventures made?
4see Ventures has 9 tracked investments.
What stage does 4see Ventures invest at?
4see Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
What is 4see Ventures's typical check size?
4see Ventures typically writes checks of $432K – $1.1M.
What sectors does 4see Ventures focus on?
4see Ventures focuses on Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, Enterprise Software, Fintech, FoodTech, Healthtech, Impact & Social Good, Medical Devices, Robotics, SaaS.
Where is 4see Ventures located?
4see Ventures is headquartered in Chêne-Bougeries, CH.
Who does 4see Ventures co-invest with?
4see Ventures most often shares deals with AlleyCorp, At One Ventures, Blockchain Valley Ventures, Llc, among 20 tracked co-investors.

Co-investors · 3

US Venture Partners

US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.

$500K – $10M
Forbion

Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.

New Leaf Venture Partners

New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.

Firms observed investing alongside 4see Ventures, from public investor directories. Shared companies are the overlap with 4see Ventures's recorded portfolio.

Similar investors

Featured in lists